Top Markets
Coin of the day
Gilead Sciences, Inc. Gilead Sciences, Inc.

Gilead Sciences, Inc.

GILD
Clasificación en acciones #100
Gilead Sciences, Inc. is a global biopharmaceutical enterprise, with operations... Gilead Sciences, Inc. is a global biopharmaceutical enterprise, with operations spanning the United States, Europe, and numerous international markets. Its core mission involves discovering, developing, and commercializing innovative medications to address critical health needs. The company's extensive product portfolio encompasses treatments for a variety of severe conditions. For HIV/AIDS, it supplies key therapies such as Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/Eviplera, Stribild, and Atripla. In response to the 2019 coronavirus pandemic, Gilead provides Veklury, an injectable drug for intravenous administration. Its offerings for liver diseases include Epclusa, Harvoni, Vosevi, Vemlidy, and Viread. Furthermore, Gilead assists patients battling hematological disorders, various cancers, and those undergoing cell therapy, through products like Yescarta, Tecartus, Trodelvy, and Zydelig. Other specialized medicines include Letairis, an oral drug for pulmonary arterial hypertension; Ranexa, also an oral medication, for chronic angina; and AmBisome, a liposomal formulation designed to combat serious invasive fungal infections. Gilead Sciences, Inc. actively engages in collaboration agreements with a diverse range of partners to advance its therapeutic pipeline. These include Arcus Biosciences, Inc., Pionyr Immunotherapeutics Inc., Tizona Therapeutics, Inc., Tango Therapeutics, Inc., Jounce Therapeutics, Inc., Galapagos NV, Janssen Sciences Ireland Unlimited Company, Japan Tobacco, Inc., Gadeta B.V., Bristol-Myers Squibb Company, Dragonfly Therapeutics, Inc., and Merck & Co, Inc. The company was founded in 1987 and its corporate headquarters are situated in Foster City, California.
Precio por acción
$150.78
Última sincronización: 2026-09-18
Capitalización bursátil
$187.20B
Cambio (1 día)
-0.08%
Cambio (1 año)
32.15%
País
US
Comercio Gilead Sciences, Inc. (GILD)

Categoría

Historial del precio de la acción de Gilead Sciences, Inc. (GILD)
Precio más alto de cierre: $148.05 el 2026-09-01

Precio más bajo de cierre: $0.68 el 1992-01-01
Historial del precio de la acción de Gilead Sciences, Inc. desde 1992 hasta 2026
Desempeño anual del precio de la acción
Año Rendimiento
2026 (TTM) 7.70%
2025 32.61%
2024 15.91%
2023 -8.13%
2022 21.80%
2021 20.36%
2020 -10.67%
2019 1.05%
2018 -11.26%
2017 0.81%
2016 -28.48%
2015 2.18%
2014 36.94%
2013 97.77%
2012 89.46%
2011 6.00%
2010 -17.53%
2009 -5.59%
2008 2.32%
2007 41.64%
2006 23.63%
2005 49.13%
2004 22.34%
2003 58.83%
2002 9.37%
2001 62.17%
2000 85.80%
1999 26.99%
1998 -1.76%
1997 35.46%
1996 -4.73%
1995 201.99%
1994 -24.84%
1993 -22.36%
1992 0.00%
Precio de la acción de empresas similares o competidoras
Empresa Precio de la acción Cambio 1a% País
$1.15K 53.22%
US
$269.75 53.10%
US
$263.75 18.56%
US
$474.96 36.76%
CH
$146.40 79.61%
US